id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-D-0529-0005,FDA,FDA-2012-D-0529,"Organ-Specific Warnings: Internal Analgesic, Antipyretic, and
Antirheumatic Drug Products for Over-the-Counter Human Use -
Labeling for Products That Contain Acetaminophen Guidance for Industry",Other,Guidance,2015-11-17T05:00:00Z,2015,11,2015-11-17T05:00:00Z,,2024-11-07T23:32:52Z,,1,0,0900006481d4d801
FDA-2012-D-0529-0004,FDA,FDA-2012-D-0529,"Organ-Specific Warnings: Internal Analgesic, Antipyretic, and
Antirheumatic Drug Products for Overthe-Counter Human Use—Labeling for Products That Contain Acetaminophen; Guidance for
Industry; Availability",Notice,Notice of Availability,2015-11-17T05:00:00Z,2015,11,2015-11-17T05:00:00Z,,2015-11-17T14:30:25Z,2015-29281,0,0,0900006481d4d3e9